Rachelle is the CEO of the LIGHT Consortium, a UK-government funded research programme consortium led by LSTM and working with partners in Kenya, Uganda, Malawi and Nigeria.
Rachelle has worked in the field of access to medicines for more than 15 years. In her previous capacity as a policy adviser in the UK government’s Department for International Development (2012-2017), she led on global and regional policy interventions across the value chain to improve access to health commodities by the poor. Rachelle is also a consultant to the Bill & Melinda Gates Foundation, supporting the implementation of the African Medicines Regulatory Harmonization initiative (AMRH) and efforts to develop the African Medicines Agency (AMA). As an independent consultant in medicines access, Rachelle conducts various pieces of analysis for different clients, recently including a landscape analysis for WHO of medicines pricing policies in Tanzania, Uganda and Ghana, as well as a landscaping analysis for PATH on health innovation policies in Africa.
Working for the UK Intellectual Property Office (2008-2011), Rachelle helped to develop the UK international strategy for intellectual property policy and created a policy evaluation function. Prior to this, as Head of Research, she established and ran the research team on intellectual property policy at a non-departmental UK government advisory body (SABIP). Rachelle has also held senior management roles at the Centre for the Management of Intellectual Property in Health R&D (MIHR), a technical assistance programme funded by the Rockefeller Foundation and Wellcome Trust, and advised BTG Plc; the ABPI; the University of Toronto and Results for Development (R4D), among others, on issues related to access to medicines.
Rachelle received her MsC from the Science Policy Research Unity at Sussex University and a BA from Manchester University. She also worked on a PhD at LSHTM.